Диссертация (1145849), страница 26
Текст из файла (страница 26)
Endoglin (CD105): a review of its rolein angiogenesis and tumor diagnosis, progression and therapy //Anticancerresearch. – 2011. – V. 31. – №. 6. – P. 2283-2290.203. Nemeth K., Keane-Myers A., Brown J.M., Metcalfe D.D., Gorham J.D., BundocV.G., Hodges M.G., Jelinek I., Madala S., Karpati S., Mezey E.
Bone marrowstromal cells use TGFβ to suppress allergic responses in a mouse model ofragweed-induced asthma //Proceedings of the National Academy of Sciences. –2010. – V. 107. – №. 12. – P. 5652-5657.204. Newman R.E., Yoo D., LeRoux M.A., Danilkovitch-Miagkova A. Treatment ofinflammatory diseases with mesenchymal stem cells //Inflammation & AllergyDrug Targets (Formerly Current Drug Targets-Inflammation & Allergy).
–2009. – V. 8. – №. 2. – P. 110-123.205. Noble P.B., Cutts J.H., Carroll K.K. Ficoll flotation for the separationof blood leukocyte types //Blood – 1968. – V.31. – P.66-73.206. Novotny N.M., Markel T.A., Crisostomo P.R., Meldrum D.R. Differential IL-6and VEGF secretion in adult and neonatal mesenchymal stem cells: role ofNFkB //Cytokine. – 2008. – V. 43. – №. 2. – P. 215-219.207. O'Dea E., Hoffmann A.
The regulatory logic of the NF-κB signaling system//Cold Spring Harbor perspectives in biology. – 2010. – V. 2. – №. 1. – P.a000216.149208. Ogulur I., Gurhan G., Kombak F.E., Filinte D., Barlan I., Akkoc T. 2014.Allogeneic pluripotent stem cells suppress airway inflammation in murinemodel of acute asthma //International immunopharmacology. – 2014. – V.
22. –№. 1. – P. 31-40.209. Okamura Y., Watari M., Jerud E.S., Young D.W., Ishizaka S.T., Rose J., ChowJ.C., Strauss J.F. The extra domain A of fibronectin activates Toll-like receptor4 //Journal of Biological Chemistry. – 2001. – V. 276. – №. 13. – P. 1022910233.210. O'Neill L.A.J., Bowie A.G. The family of five: TIR-domain-containing adaptorsin Toll-like receptor signalling //Nature Reviews Immunology. – 2007.
– V. 7. –№. 5. – P. 353-364.211. Opitz C.A., Litzenburger U.M., Lutz C., Lanz T.V., Tritschler I., Köppel A.,Tolosa E., Hoberg M., Anderl J., Aicher W.K., Weller M., Wick W., Platten M.Toll-Like Receptor Engagement Enhances the Immunosuppressive Properties ofHuman Bone Marrow-Derived Mesenchymal Stem Cells by InducingIndoleamine-2, 3-dioxygenase-1 via Interferon-β and Protein Kinase R //StemCells.
– 2009. – V. 27. – №. 4. – P. 909-919.212. Oswald J., Boxberger S., Jorgensen B., Feldmann S., Ehninger G., BornhuserM., Werner C. Mesenchymal stem cells can be differentiated into endothelialcells in vitro //Stem cells. – 2004. – V. 22. – №. 3. – P. 377-384.213. Pan Z.K, Fisher C., Li J.D., Jiang Y., Huang S., Chen L.Y.. Bacterial LPS upregulated TLR3 expression is critical for antiviral response in humanmonocytes: evidence for negative regulation by CYLD //Internationalimmunology. – 2011. – V.23. – P. 357–364.214. Panepucci R.A., Siufi J.L., Silva W.A.
Jr., Proto-Siquiera R., Neder L., OrellanaM., Rocha V., Covas D.T., Zago M.A. Comparison of gene expression ofumbilical cord vein and bone marrow–derived mesenchymal stem cells //Stemcells. – 2004. – V. 22. – №. 7. – P. 1263-1278.215. Parham P. The immune system. – Garland Science, 2009.216. Park B.S., Lee J.O.
Recognition of lipopolysaccharide pattern by TLR4complexes //Experimental & molecular medicine. – 2013. – V. 45. – №. 12. – P.e66.217. Pasarica M., Sereda O.R., Redman L.M., Albarado D.C., Hymel D.T., RoanL.E., Rood J.C., Burk D.H., Smith S.R. Reduced adipose tissue oxygenation inhuman obesity evidence for rarefaction, macrophage chemotaxis, andinflammation without an angiogenic response //Diabetes.
– 2009. – V. 58. – №.3. – P. 718-725.150218. Paul W.E. Interleukin-4: a prototypic immunoregulatory lymphokine //Blood. –1991. – V. 77. – №. 9. – P. 1859-1870.219. Payne N.L., Sun G., McDonald C., Layton D., Moussa L., Emerson-Webber A.,Veron N., Siatskas C., Herszfeld D., Price J., Bernard, C.C. Distinctimmunomodulatory and migratory mechanisms underpin the therapeuticpotential of human mesenchymal stem cells in autoimmune demyelination //Celltransplantation. – 2013.
– V. 22. – №. 8. – P. 1409-1425.220. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D.,Moorman M.A., Simonetti D.W., Craig S., Marshak D.R. Multilineage potentialof adult human mesenchymal stem cells //science. – 1999. – V. 284. – №. 5411.– P. 143-147.221. Płóciennikowska A., Hromada-Judycka A., Borzęcka K., Kwiatkowska K. Cooperation of TLR4 and raft proteins in LPS-induced pro-inflammatory signaling//Cellular and Molecular Life Sciences.
– 2015. – V. 72. – №. 3. – P. 557-581.222. Pohl D., Andrýs C., Borská L., Fiala Z., Hamaková K., Ettler K., Krejsek J.Serum level of a soluble form of endoglin (CD105) is decreased afterGoeckerman's therapy of psoriasis //Acta Medica (Hradec Kralove). – 2011. –V. 54. – №. 2. – P. 59-62.223. Prasanna S.J., Gopalakrishnan D., Shankar S.R., Vasandan A.B. Proinflammatory cytokines, IFNγ and TNFα, influence immune properties ofhuman bone marrow and Wharton jelly mesenchymal stem cells differentially//PLoS One. – 2010. – V. 5. – №.
2. – P. e9016.224. Qian H., Le Blanc K., Sigvardsson M. Primary mesenchymal stem andprogenitor cells from bone marrow lack expression of CD44 protein //Journal ofBiological Chemistry. – 2012. – V. 287. – №. 31. – P. 25795-25807.225. Quaedackers M.E., Baan C.C., Weimar W., Hoogduijn M.J. Cell contactinteraction between adipose-derived stromal cells and allo-activated Tlymphocytes //European journal of immunology. – 2009. – V. 39. – №. 12. – P.3436-3446.226.
Rada T., Reis R.L., Gomes M.E. Distinct stem cells subpopulations isolatedfrom human adipose tissue exhibit different chondrogenic and osteogenicdifferentiation potential //Stem Cell Reviews and Reports. – 2011. – V. 7. – №.1. – P. 64-76.227. Radulovic K., Manta C., Rossini V., Holzmann K., Kestler H.A., WegenkaU.M., Nakayama T., Niess J.H. CD69 regulates type I IFN-induced tolerogenicsignals to mucosal CD4 T cells that attenuate their colitogenic potential //TheJournal of Immunology. – 2012.
– V. 188. – №. 4. – P. 2001-2013.151228. Raicevic G., Najar M., Stamatopoulos B., De Bruyn C., Meuleman N., Bron D.,Toungouz M., Lagneaux L. The source of human mesenchymal stromal cellsinfluences their TLR profile as well as their functional properties //Cellularimmunology. – 2011. – V. 270. – №. 2. – P. 207-216.229. Rahman M.M., Subramani J., Ghosh M., Denninger J.K., Takeda K., Fong G.H.,Carlson M.E., Shapiro L.H. CD13 promotes mesenchymal stem cell-mediatedregeneration of ischemic muscle //Frontiers in physiology. – 2013. – V. 4.230. Ramasamy R., Tong C.K., Seow H.F., Vidyadaran S., Dazzi F.
Theimmunosuppressive effects of human bone marrow-derived mesenchymal stemcells target T cell proliferation but not its effector function //Cellularimmunology. – 2008. – V. 251. – №. 2. – P. 131-136.231. Rasmusson I., Le Blanc K., Sundberg B., Ringdén O. Mesenchymal stem cellsstimulate antibody secretion in human B cells //Scandinavian journal ofimmunology. – 2007.
– V. 65. – №. 4. – P. 336-343.232. Rebelatto C.K., Aguiar A.M., Moretão M.P., Senegaglia A.C., HansenP., Barchiki F., Oliveira J., Martins J., Kuligovski C., Mansur F., ChristofisA., Amaral V.F., Brofman P.S., Goldenberg S., Nakao L.S., Correa A.Dissimilar differentiation of mesenchymal stem cells from bone marrow,umbilical cord blood, and adipose tissue //Experimental Biology and Medicine.– 2008. – V.
233. – №. 7. – P. 901-913233. Rege T.A., Hagood J.S. Thy-1 as a regulator of cell-cell and cell-matrixinteractions in axon regeneration, apoptosis, adhesion, migration, cancer, andfibrosis //The FASEB journal. – 2006. – V. 20. – №. 8. – P. 1045-1054.234. Ribeiro A., Laranjeira P., Mendes S., Velada I., Leite C., Andrade P., Paiva A.Mesenchymal stem cells from umbilical cord matrix, adipose tissue and bonemarrow exhibit different capability to suppress peripheral blood B, natural killerand T cells //Stem Cell Res Ther. – 2013. – V.
4. – №. 5. – P. 125.235. Rosado M.M., Bernardo M.E., Scarsella M., Conforti A., Giorda E., Biagini S.,Cascioli S., Rossi F., Guzzo I., Vivarelli M., Dello Strologo L., EmmaF. Locatelli F., Carsetti R. Inhibition of B-cell proliferation and antibodyproduction by mesenchymal stromal cells is mediated by T cells //Stem cells anddevelopment. – 2015. – V. 24. – №.
1. – P. 93-103.236. Rossant J. Stem cells from the mammalian blastocyst. //Stem cells. – 2001. – V.19. – №. 6. – P. 477-482.237. Romieu-Mourez R., François M., Boivin M.N., Bouchentouf M., Spaner D.E.,Galipeau J. Cytokine modulation of TLR expression and activation inmesenchymal stromal cells leads to a proinflammatory phenotype //The Journalof Immunology. – 2009. – V.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
